Lv4
448 积分 2024-11-03 加入
Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money
2个月前
已完结
Clinical outcomes and cost savings of a nonmedical switch to a biosimilar in children/young adults with inflammatory bowel disease
2个月前
已完结
Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis
2个月前
已完结
Impact of pediatric inflammatory bowel disease on caregivers' work productivity: A multicenter study by the SEGHNP
2个月前
已完结
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model
2个月前
已完结
Antagonistas del factor de necrosis tumoral (TNF) en la enfermedad inflamatoria intestinal pediátrica: Una revisión sistemática
2个月前
已关闭
Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study
2个月前
已完结
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress
2个月前
已完结
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children
2个月前
已完结
Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study
2个月前
已完结
皖公网安备34019202002308
